Showing items 321-330 of 1111 (112 Page(s) Totally)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.;Lin H.-H.;Hong-Jeng Yu;Cheng C.-L.;Hung M.-J.;Lin A.T.L.; Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2021-02-01T02:11:08Z |
Mortality, morbidity, and risk factors in Taiwan, 1990–2017: findings from the Global Burden of Disease Study 2017
|
Wu Y.-C.;Lo W.-C.;Lu T.-H.;Shu-Sen Chang;Lin H.-H.;Chan C.-C.; Wu Y.-C.; Lo W.-C.; Lu T.-H.; SHU-SEN CHANG; Lin H.-H.; Chan C.-C. |
| 臺大學術典藏 |
2021-01-29T03:17:30Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Lin H.-H.;Shih-Ping Liu;Huang K.-H.;Yu H.-J.; Ho C.-H.; Chang T.-C.; Lin H.-H.; SHIH-PING LIU; Huang K.-H.; Yu H.-J. |
| 臺大學術典藏 |
2021-01-28T02:03:41Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Lin H.-H.;Liu S.-P.;Kuo-How Huang;Yu H.-J.; Ho C.-H.; Chang T.-C.; Lin H.-H.; Liu S.-P.; KUO-HOW HUANG; Yu H.-J. |
| 臺大學術典藏 |
2021-01-26T03:36:46Z |
The Kunitz Domain i of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
|
Wu S.-R.;Teng C.-H.;Tu Y.-T.;Ko C.-J.;Cheng T.-S.;Lan S.-W.;Lin H.-Y.;Lin H.-H.;Tu H.-F.;Hsiao P.-W.;Huang H.-P.;Chung-Hsin Chen;Lee M.-S.; Wu S.-R.; Teng C.-H.; Tu Y.-T.; Ko C.-J.; Cheng T.-S.; Lan S.-W.; Lin H.-Y.; Lin H.-H.; Tu H.-F.; Hsiao P.-W.; Huang H.-P.; CHUNG-HSIN CHEN; Lee M.-S. |
| 臺大學術典藏 |
2021-01-26T03:36:46Z |
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis
|
Ko C.-J.;Lan S.-W.;Lu Y.-C.;Cheng T.-S.;Lai P.-F.;Tsai C.-H.;Hsu T.-W.;Lin H.-Y.;Shyu H.-Y.;Wu S.-R.;Lin H.-H.;Hsiao P.-W.;Chung-Hsin Chen;Huang H.-P.;Lee M.-S.; Ko C.-J.; Lan S.-W.; Lu Y.-C.; Cheng T.-S.; Lai P.-F.; Tsai C.-H.; Hsu T.-W.; Lin H.-Y.; Shyu H.-Y.; Wu S.-R.; Lin H.-H.; Hsiao P.-W.; CHUNG-HSIN CHEN; Huang H.-P.; Lee M.-S. |
| 臺大學術典藏 |
2021-01-26T03:36:42Z |
Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells (Scientific Reports, (2017), 7, 1, (15101), 10.1038/s41598-017-15415-4)
|
Wu S.-R.; Teng C.-H.; Tu Y.-T.; Ko C.-J.; Cheng T.-S.; Lan S.-W.; Lin H.-Y.; Lin H.-H.; Tu H.-F.; Hsiao P.-W.; Huang H.-P.; CHUNG-HSIN CHEN; Lee M.-S. |
| 臺大學術典藏 |
2021-01-19T12:08:32Z |
Interpretable Neural Network to Model and to Reduce Self-Heating of FinFET Circuitry
|
Chung, Chia Che; Lin, Hsin Cheng; Lin, H. H.; Wan, W. K.; Yang, M. T.; CHEN-WUING LIU |
| 臺大學術典藏 |
2021-01-12T12:49:15Z |
Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma
|
SHANG-YI HUANG; Chen B.-B.; Lu H.-Y.; Lin H.-H.; Wei S.-Y.; Hsu S.-C.; Shih T.T.-F. |
Showing items 321-330 of 1111 (112 Page(s) Totally)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
View [10|25|50] records per page
